IDIOPATHIC INFLAMMATORY MYOSITIS

Clinical trials for IDIOPATHIC INFLAMMATORY MYOSITIS explained in plain language.

Never miss a new study

Get alerted when new IDIOPATHIC INFLAMMATORY MYOSITIS trials appear

Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New injection tested for rare autoimmune muscle disease

Disease control Completed

This study tested whether daxdilimab, given as an injection under the skin, could reduce disease activity in adults with dermatomyositis or anti-synthetase inflammatory myositis—two rare autoimmune conditions that cause muscle weakness and skin rashes. The 12 participants were ra…

Matched conditions: IDIOPATHIC INFLAMMATORY MYOSITIS

Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control

Last updated Mar 13, 2026 15:06 UTC

IDIOPATHIC INFLAMMATORY MYOSITIS

Get alerted when new IDIOPATHIC INFLAMMATORY MYOSITIS trials appear

New injection tested for rare autoimmune muscle disease